Capital Markets

• Morgan Stanley Asia Limited, China International Capital Corporation Hong Kong Securities Limited, and UBS Securities Hong Kong Limited as joint sponsors in the US$130.3 million global offering and IPO on the Main Board of the SEHK of Weilong Delicious Global Holdings Ltd. ("Weilong"). Weilong is a Chinese spicy snack food maker with a top ranking among all spicy snack food enterprises in China.
• Onewo Inc., a leading property management service provider in China and a subsidiary of China Vanke, on its US$738 million global offering and spin-off listing on the Main Board of the Hong Kong Stock Exchange. CLSA Capital Markets Limited, Citigroup Global Markets Asia Limited and Goldman Sachs (Asia) L.L.C. acted as the joint sponsors.
• China International Capital Corporation Hong Kong Securities Limited and CMB International Capital Limited (in no particular order) as joint sponsors and joint global coordinators in the global offering and IPO on the Main Board of the SEHK of Dingdang Health Technology Group Ltd ("Dingdang Health"). Dingdang Health is a service provider in providing express digital healthcare services in China.
• China International Capital Corporation Hong Kong Securities Limited as the sole sponsor together with Macquarie Capital, CMBI, BOCI and other underwriters on the US$71 million global offering and listing of TI Cloud Inc., one of the largest providers of customer contact solutions deployed in public clouds in China, on the Main Board of the Hong Kong Stock Exchange.
• Morgan Stanley Asia Limited and China International Capital Corporation Hong Kong Securities Limited as the joint sponsors in the US$394 million global offering and listing of Cheerwin Group Limited, a leading household care and personal care platform in China, on the Main Board of the Hong Kong Stock Exchange.
• Morgan Stanley Asia Limited, China International Capital Corporation Hong Kong Securities Limited and Credit Suisse as the joint sponsors on the US$281 million global offering and initial public offering of SciClone Pharmaceuticals, a leading biopharmaceutical company based in China, on the Main Board of the Hong Kong Stock Exchange.
• ABCI Capital Limited, CLSA Capital Markets Limited and Haitong International Capital Limited as the joint sponsors on the US$331 million global offering and IPO of Radiance Holdings, a leading Chinese property developer, on the Main Board of the Hong Kong Stock Exchange.
• SinoMab BioScience Limited, a biopharmaceutical company dedicated to R&D of therapeutics for the treatment of immunological diseases, in its US$176.5 million global offering and IPO on the Main Board of the Hong Kong Stock Exchange as a Chapter 18A biotech company. China International Capital Corporation Hong Kong Securities Limited and Orient Capital Limited acted as the joint sponsors.

Compliance Matters

• Represented a number of listed companies, including China Vanke Co., Ltd, China International Marine Containers (Group) Co., Ltd (CIMC), Fosun Tourism Group, Phoenix Media, Liaoning Port Co., Ltd. (formerly known as Dalian Port (PDA) Company Limited) and Bank of Tianjin in relation to their compliance matters under the Hong Kong Listing Rules and other relevant laws and regulations.

M&A, PE and Financing

• Represented China Development Bank, SMBC and Financiera de Desarrollo Nacional in financing the development, construction and operation of the 4G road Autopista al Mar 2 in Colombia.
• JHJ Logistics, a company led by former executives with The Carlyle Group’s Asia real estate platform, in connection with the formation of a joint venture with Jaguar Growth Partners, and the joint venture’s acquisition of Brilliant Enterprise Management Consulting, a leading warehouse, distribution and logistics property company in China.